Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-Line Clinical Trials. jkcvhl 2024, 11 (3), 51-58. https://doi.org/10.15586/jkcvhl.v11i3.352.